The World Health Organization's "healthy" BMI range (18.5–24.9 kg/m²) was derived from pooled population-level mortality data in mostly younger cohorts, with a median age in the 30s. A large body of geriatric-medicine research since the early 2000s has shown that the BMI band that minimises all-cause mortality in adults 65+ is shifted slightly upward — to roughly 24.0–27.0 kg/m² in most meta-analyses, and to a higher point estimate in several regional studies.
The 2014 prospective-cohort analysis of the Cardiovascular Health Study (Winter et al., Am J Clin Nutr 2014) followed 4,469 community-dwelling adults aged 65+ for a median of 14 years and found the lowest mortality risk in the BMI range 24.0–27.4 in men and 25.0–29.4 in women — well into what the WHO labels "overweight". A 2013 meta-analysis in the American Journal of Clinical Nutrition (Flegal et al., 2013) pooled 2.88 million adults across 97 studies and found the same J-curve: "overweight" (BMI 25–29.9) was associated with lower all-cause mortality than "normal" (BMI 18.5–24.9) in older adults.
But: the J-curve is partly reverse causation
The story is more nuanced than "BMI 27 is healthier than BMI 22 in 70-year-olds". Two confounding factors push the apparent optimal range upward:
- Reverse causation from illness-related weight loss. Many chronic diseases (cancer, heart failure, advanced COPD, dementia) cause weight loss before they cause death. The statistical effect of being thin at age 70 therefore includes undiagnosed illness, not just a healthy constitution. Studies that exclude the first 5 years of follow-up (so the already-ill are removed) consistently find a narrower U-curve and a slightly lower optimum.
- Sarcopenia. The single biggest confounder. From age 30, adults lose 3–8% of their muscle mass per decade; this accelerates after 60. A 70-year-old with a BMI of 22 and a body-fat percentage of 35% is in worse cardiometabolic shape than a 70-year-old with a BMI of 27 and a body-fat percentage of 25%, even though the first is "normal" and the second is "overweight". BMI cannot distinguish the two.
So the right way to read the evidence is: in adults 65+, the optimal BMI is somewhere in the 24–27 range, with a tighter U-curve and a higher optimal point than younger adults. The wrong way to read it is: "BMI 30 is healthier than BMI 22 at any age". Neither the WHO nor the geriatric societies have made that second claim.
What this means in practice
- A BMI in the 24–27 range is reasonable to aim for, with the caveat that body composition, waist circumference, grip strength and gait speed are more informative than the BMI number itself.
- Weight loss in older age is higher-risk than in younger age. The National Institute on Aging, the American Geriatrics Society, and the European Society for Clinical Nutrition and Metabolism (ESPEN) all caution against voluntary weight loss in adults 65+ unless BMI is ≥ 30, the loss is supervised, and protein intake (≥ 1.0–1.2 g/kg per day) is maintained.
- A BMI < 22 in an older adult is a red flag for sarcopenia, malnutrition, undiagnosed illness, or all three. It warrants a clinical workup, not praise.
Pair BMI with these other numbers
For adults 65+, the clinical and geriatric consensus is that BMI is the first screen and not the last. The numbers a geriatrician or good primary-care physician will actually track alongside it are:
- Hand-grip strength — the best single proxy for total muscle function. A reading below the 25th percentile for age and gender (dynapenia) is associated with higher fall risk, hospital length-of-stay, and post-operative complications independent of BMI.
- Gait speed over 4 metres — the "vital sign" of geriatric medicine. Below 0.8 m/s is a known marker of frailty and predicts 5-year mortality as well as any single laboratory value.
- Waist circumference — the visceral-fat signal BMI misses. The target is < 102 cm (40 in) for men and < 88 cm (35 in) for women. This is the cardiometabolic-risk number that matters more than BMI in the 24+ range.
- Body-fat percentage (Deurenberg, on the calculator result panel) — to flag sarcopenic obesity (low muscle, high fat) which BMI under-counts.
How to use this calculator
- Type your height, weight, age and gender in the units you have.
- Read your WHO BMI and category.
- Look at the body-fat percentage — the "normal" BMI of 22 with a body-fat of 35% is worse than the "overweight" BMI of 27 with a body-fat of 25%.
- Open the optional waist input to get a waist-to-height ratio and an explicit cardiometabolic risk label.
- Talk to your clinician about the four numbers above if your BMI is below 22, above 30, or changing faster than ~3 kg in 6 months.
When the WHO under-25 target is still the right call
The WHO 18.5–24.9 range is still the right clinical target if you are:
- 55–64 (the "younger" older adult — the J-curve evidence is weaker here and the cardiometabolic- risk signal of overweight is stronger).
- Pre-operative (anaesthesia and surgical outcomes are worse at BMI ≥ 30 regardless of age).
- Managing type-2 diabetes, hypertension or established cardiovascular disease, where weight loss at any age is a guideline-supported intervention.
References
- Winter JE, MacInnis RJ, Wattanapenpaiboon N, Nowson CA. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr. 2014;99(4):875–890. PubMed 24632894.
- Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82. PubMed 23283503.
- Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr. 2019;38(1):10–47. Clinical Nutrition 2019.
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. Age and Ageing 2019.
- Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50–58. PubMed 21205966.